Paul A. Wilks, Jr.

Paul A. Wilks, Jr. begins the interview by discussing his early years and family life in Springfield, Massachusetts. After graduating from Springfield Technical High School, Wilks went to Harvard University, where he majored in engineering. In 1945, he began working at Perkin-Elmer, Inc. (now PerkinElmer). Wilks worked as an assembler before becoming marketing director in 1952. In 1957, Wilks left PerkinElmer and, with Charles W. Warren, founded the Connecticut Instrument Company, a company that manufactured accessories for the infrared industry. Wilks and Warren sold their company to R. Bowling Barnes in 1962. After working for the Barnes Engineering Company for a year as commercial products manager, Wilks left to form the Wilks Scientific Corporation. This company manufactured a variety of spectroscopy products. Wilks hired Anthony C. Gilby, an infrared spectroscopist from England, who helped in the development of these products. This company was sold to the Foxboro Company in the 1970s, and Wilks managed the Wilks division of the company until 1979. After leaving Foxboro, Wilks founded the General Analysis Corporation to market products that monitored workspace environments. The company was unable to create a market in this area and changed its focus towards producing products for other industries, such as the beverage industry. Wilks decided to retire in 1993 and General Analysis was eventually sold to OI Corporation. Although theoretically retired, Wilks started another company in the 1990s, Wilks Enterprise, Inc. This company continues Wilks' efforts to produce applicable products based on infrared spectroscopy and other technologies. Wilks concludes the interview with reflections on the state of infrared technology and thoughts about his career.

PerkinElmer

1944 - 1952 Assembler/Designer

PerkinElmer

1952 - 1957 Director, Marketing

Connecticut Instrument Company

1957 - 1962 Co-Founder and Assistant CEO

Barnes Engineering Company

1962 - 1963 Manager, Commercial Products

Wilks Scientific Corporation

1963 - 1977 Founder and CEO

Foxboro Company

1977 - 1979 Manager, Foxboro Wilks Division

General Analysis Corporation

1979 - 1993 Founder and CEO

General Analysis Corporation

1993 - 1999 Member, Board of Directors

Wilks Enterprise, Inc.

1997 Founder and CEO

David C. Brock

David C. Brock is a senior research fellow with the Center for Contemporary History and Policy at the Chemical Heritage Foundation. As a historian of science and technology, he specializes in the history of semiconductor science, technology, and industry; the history of instrumentation; and oral history. Brock has studied the philosophy, sociology, and history of science at Brown University, the University of Edinburgh, and Princeton University.

In the policy arena Brock recently published Patterning the World: The Rise of Chemically Amplified Photoresists, a white-paper case study for the Center’s Studies in Materials Innovation. With Hyungsub Choi he is preparing an analysis of semiconductor technology roadmapping, having presented preliminary results at the 2009 meeting of the Industry Studies Association.

Arthur Daemmrich

Arthur Daemmrich is an assistant professor in the Business, Government, and International Economy Unit at Harvard Business School and a senior research fellow at the Chemical Heritage Foundation. His research examines science, medicine, and the state, with a focus on advancing theories of risk and regulation through empirical research on the pharmaceutical, biotechnology, and chemical sectors. At HBS he also plays an active role in an interdisciplinary Healthcare Initiative, advancing scholarship and developing applied lessons for the business of creating and delivering health services and health-related technologies. Daemmrich was previously the director of the Center for Contemporary History and Policy at the Chemical Heritage Foundation. He earned a Ph.D. in Science and Technology Studies from Cornell University in 2002 and has held fellowships at the Social Science Research Council/Berlin Program for Advanced German and European Studies, the Kennedy School of Government at Harvard University, and the Chemical Heritage Foundation. He has published widely on pharmaceutical and chemical regulation, biotechnology business and policy, innovation, and history of science.